Troxerutin 98% Tested By HPLC, UV

Assay :95.0% - 102.0% By HPLC Export to Asia, USA and EuropeCAS NO.: 7085-55-4 Molecular Formula: C33H42O19Molecular Weight: 742.68Standard: EP 5.3/EP6/DAB1999Details of SpecificationName: TroxerutinAssay :95.0% - 102.0% Export to Asia, USA and EuropeCAS NO.: 7085-55-4 Molecular Formula: C33H42O19Molecular Weight: 742.68 Name: TroxerutinAssay :95.0% - 102.0% Export to Asia, USA and EuropeCAS NO.: 7085-55-4 Molecular Formula: C33H42O19Molecular Weight: 742.68Standard: EP 5.3/EP6/DAB1999Chemical name : 2-[3,4-Bis(2-hydroxyethoxy)phenyl]-5-hydroxy-7-(2-hydroxy-ethoxy)-3-(6-O-a-L-rhamnopyranosyl-b-D-glucopyranosyloxy)-4H-chromen-4-onOther names:7,3',4'-Tris[O-(2-hydroxyethyl)] rutin; trioxyethylrutin; tri(hydroxyethyl) rutosidePhysical form: Yellowish green powderMelting point:168 176°CM. F. & M. W. : C33H42O19Assay:95.0% - 102.0%Particle size: 100% pass through 80 meshMain peak: ≥80.0%One peak:≤10.00%Single peak: ≤5.0%Ethylene oxide:≤1ppmHeavy metals: ≤10.0ppmLoss on drying:≤5.0%Storage: avoid light, closeness, keep at the cool, dry placeValid: 24monthesPharmacology:This product can inhibit platelet aggregation, prevent thrombosis, can cure the vascular injury induced by 5 serotonin or bradykinin, increase the capillary resistance, reduce the capillary permeability, prevent edema caused by the increasement of vascular permeability. It has the significant protective effect to acute ischemic brain injury. ApplyingAs the treatment of cerebral thrombosis or the sequela due from the cerebral embolism, such as the hemiplegia, aphasia and myocardial infarction syndrome, arteriosclerosis, central retinitis, phlebitis of thrombosis, varicose veins, edema caused by the vascular permeability rising.SHANDONG LUKAND DAYU PHARMACEUTICAL CO., LTD.ADD: NO.1, TIEBEI STREET, YANZHOU CITY, SHANDONGTEL:86-537-3488911FAX:86-537-3412369CELL PHONE: 86-15953483864